13 reports

  • R&D Progress Research and Development Brief

The study included positive control sibutramine (## mg/ kg once daily, ##. ## percent weight loss), a serotonin and noradrenaline reuptake inhibitor, which is currently marketed for the treatment of obesity.

  • Obesity
  • Therapy
  • United States
  • World
  • Product Initiative
  • R&D Progress Research and Development Brief

The study included positive control sibutramine (## mg/ kg once daily, ##. ## percent weight loss), a serotonin and noradrenaline reuptake inhibitor, which is currently marketed for the treatment of obesity.

  • Hormone
  • Obesity
  • Therapy
  • World
  • Product Initiative
  • Nov 16, 2017: Krka presented its operating results for the period January-September 2017

The medicine from the group of combined serotonin and noradrenaline reuptake inhibitors is used to treat depression, generalised anxiety disorder and neuropathic pain in diabetes.

  • Healthcare
  • Pharmaceutical
  • Slovenia
  • Demand
  • Krka Group
  • CSTI-100 - DRUG PROFILE

The study included positive control sibutramine (## mg/ kg once daily, ##. ## percent weight loss), a serotonin and noradrenaline reuptake inhibitor, which is currently marketed for the treatment of obesity.

  • Neurological Disorder
  • Obesity
  • Pharmaceutical
  • Therapy
  • United States
  • 5. All the trials included are unique trials.

Lundbeck AS ## Jan 2005 ## Jan 2005 ## Feb 2012 ## ## ## ## ## Sodium Dependent Serotonin Transporter (##HT Transporter or ##HTT or Solute Carrier Family ## Member ## or SLC##A##) Inhibitor Sodium Dependent Serotonin Transporter (##HT Transporter or ##HTT or Solute Carri

  • Clinical Trial
  • Depression
  • Hospital
  • Neurology
  • Therapy
  • Serotonin-Norepinephrine Reuptake Inhibitors

TO BE PRECISE, SMSS SIMULTANEOUSLY MODULATE ONE OR MORE SEROTONIN RECEPTORS AND INHIBIT THE REUPTAKE OF SEROTONIN.

  • Antidepressant
  • Hormone
  • Therapy
  • China
  • Demand
  • Serotonin-Norepinephrine Reuptake Inhibitors

TO BE PRECISE, SMSS SIMULTANEOUSLY MODULATE ONE OR MORE SEROTONIN RECEPTORS AND INHIBIT THE REUPTAKE OF SEROTONIN.

  • Antidepressant
  • Pharmaceutical
  • Therapy
  • China
  • Demand
  • Melanin-Concentrating Hormone Receptor 1 (G-

The study included positive control sibutramine (## mg/ kg once daily, ##. ##% weight loss), a serotonin and noradrenaline reuptake inhibitor, which is currently marketed for the treatment of obesity.

  • Hormone
  • Obesity
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Preferred Drugs List, as at August 2016

In June 2016, the Sunday Business Post reported that the HSE had secured a " last-minute" confidential discount on Merck Sharp & Dohme' s PD-## inhibitor Keytruda (pembrolizumab) for the first line treatment of unresectable or advanced metastatic melanoma in adults.

  • Health Services
  • Healthcare
  • Hospital
  • Ireland
  • Supply
  • MAJOR DEPRESSIVE DISORDER - GLOBAL DRUG FORECAST AND MARKET ASSESSMENT TO 2025

ANTIDEPRESSANT EFFICACY AND TOLERABILITY OF MILNACIPRAN, A DUAL SEROTONIN and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.

  • Antidepressant
  • Depression
  • Serotonin Specific Reuptake Inhibitor
  • Therapy
  • Allergan plc
  • CSTI-100 - DRUG PROFILE

THE STUDY INCLUDED POSITIVE CONTROL SIBUTRAMINE (## MG/ KG ONCE DAILY, ##. ## PERCENT WEIGHT LOSS), A SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR, WHICH IS CURRENTLY MARKETED FOR THE TREATMENT OF OBESITY.

  • Digestive System Disorder
  • Pathology
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Jan 09, 2017: Addex ADX71441 Demonstrates Statistically Significant Efficacy in a Highly Translational Preclinical Model of Chronic Osteoarthritis Pain
  • FEATURED NEWS & PRESS RELEASES

Dec ##, 2016: " CYMBALTA Capsules ##mg ## mg" (Serotonin-noradrenaline reuptake inhibitor) Approved for an Additional Indication of Pain Associated with Osteoarthritis Shionogi & Co., Ltd and Eli Lilly Japan K. K. announced that " CYMBALTA Capsules

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • Pharmaceutical
  • Therapy
  • GLAXOSMITHKLINE PLC - DISCONTINUED PIPELINE PRODUCTS

The serotonin-noradrenaline reuptake inhibitors (SNRIs) are a class of drug that inhibit reuptake of both serotonin and noradrenaline.

  • Infectious Disease
  • Monoclonal Antibody
  • Therapy
  • Vaccine
  • GlaxoSmithKline plc